Trexquant Investment LP

Position in ZTS — Zoetis Inc.

CIK 1633445 STAMFORD, CT

Position in ZTS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$8,438,539

-$17,797,953 QoQ

Shares Held

71,386

-60.2% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 91.03745832516181.ToString("F0")% Shared 0.ToString("F0")% None 8.962541674838203.ToString("F0")%

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $120,085,995 across 26 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (7.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	183,310	$24,149,259
2	LQDA	Liquidia Corp	409,259	$15,445,434
3	VTRS	Viatris Inc	882,688	$11,925,114
4	PRGO	PERRIGO Co plc	1,011,832	$10,867,075
5	ZTS	Zoetis Inc. This page	71,386	$8,438,539
6	KNSA	Kiniksa Pharmaceuticals International, plc	135,280	$6,513,732
7	XERS	Xeris Biopharma Holdings, Inc.	833,217	$4,832,658
8	EBS	Emergent BioSolutions Inc.	524,233	$4,351,133

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$8,438,539	71,386	-60.2%	Shares	Sole	2026-05-15
2025-09-30	$26,236,492	179,309	+222.1%	Shares	Sole	2025-11-14
2025-06-30	$8,682,516	55,675	-65.5%	Shares	Sole	2025-08-12
2025-03-31	$26,573,686	161,395	-4.2%	Shares	Sole	2025-05-14
2024-12-31	$27,456,800	168,519	+47.5%	Shares	Sole	2025-02-12
2024-03-31	$19,335,965	114,272	+814.7%	Shares	Sole	2024-05-14
2023-06-30	$2,151,419	12,493	-81.4%	Shares	Sole	2023-08-11
2023-03-31	$11,188,429	67,222	+90.0%	Shares	Sole	2023-05-15
2022-12-31	$5,184,206	35,375	+10.0%	Shares	Sole	2023-02-13
2022-09-30	$4,769,896	32,166	+264.9%	Shares	Sole	2022-11-14
2022-06-30	$1,515,038	8,814	-84.1%	Shares	Sole	2022-08-11
2022-03-31	$10,472,591	55,531	—	Shares	Sole	2022-05-13
No filing history on record for this holder in this stock.